BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -330.3 Million SEK | -703.17% |
| 2022 | -4.05 Million USD | 86.76% |
| 2021 | -30.65 Million USD | -229.83% |
| 2020 | -9.29 Million USD | 37.21% |
| 2019 | -14.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -9.52 Million USD | 29.18% |
| 2024 Q1 | -7.28 Million SEK | 19.77% |
| 2024 Q2 | -137.3 Million SEK | -76.16% |
| 2023 Q1 | -7.07 Million USD | 5.48% |
| 2023 Q4 | -9.58 Million USD | -47.96% |
| 2023 FY | -32.6 Million USD | -703.17% |
| 2023 Q3 | -6.48 Million USD | 20.52% |
| 2023 Q2 | -8.15 Million USD | -15.32% |
| 2022 Q2 | 16.3 Million USD | 0.0% |
| 2022 FY | -4.05 Million USD | 86.76% |
| 2022 Q4 | -7.48 Million USD | -30.58% |
| 2022 Q3 | -5.72 Million USD | -135.13% |
| 2021 FY | -30.65 Million USD | -229.83% |
| 2020 FY | -9.29 Million USD | 37.21% |
| 2019 FY | -14.8 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -340.623% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -4922.786% |
| SQZ Biotechnologies Company | -79.46 Million USD | -315.665% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 723.462% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 607.123% |
| Mesoblast Limited | -87.95 Million USD | -275.533% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -18043.308% |
| Genus plc | 7.9 Million USD | 4281.063% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -2932.61% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -8802.511% |
| Marizyme, Inc. | -65.34 Million USD | -405.462% |
| ContraFect Corporation | -65.15 Million USD | -406.967% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -3634.781% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -6660.126% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -19020.845% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -11319.744% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -3998.226% |
| MultiCell Technologies, Inc. | -380.07 USD | -86905996.245% |
| Accustem Sciences Inc. | -3.74 Million USD | -8716.526% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -538.985% |
| EV Biologics, Inc. | -1.26 Million USD | -25967.014% |
| Q BioMed Inc. | -2.05 Million USD | -15995.957% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -8748.219% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -52129.656% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -13773.248% |
| Biomind Labs Inc. | -1.21 Million USD | -27100.76% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -3031.437% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -4079.427% |
| Skye Bioscience, Inc. | -37.64 Million USD | -777.423% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -15122.687% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -2205455.556% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -4630.227% |
| IMV Inc. | -36.48 Million USD | -805.297% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -1981.121% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -5578.006% |
| GB Sciences, Inc. | -1.36 Million USD | -24157.148% |
| Alpha Cognition Inc. | -13.77 Million USD | -2298.275% |
| HST Global, Inc. | -146.21 Thousand USD | -225810.676% |
| CSL Limited | 2.64 Billion USD | 112.502% |
| Halberd Corporation | -79.67 Thousand USD | -414458.964% |
| Enzolytics Inc. | -2.17 Million USD | -15073.61% |
| Resverlogix Corp. | -3.61 Million USD | -9049.695% |
| Affymax, Inc. | -14.42 Million USD | -2189.961% |
| SYBLEU INC | -180.3 Thousand USD | -183092.83% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -10314.967% |
| argenx SE | -295.05 Million USD | -11.947% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -427.651% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 337144.898% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -8213.732% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -10815.045% |
| AVAX Technologies, Inc. | -6.41 Million USD | -5050.018% |
| Zenith Capital Corp. | -10.59 Million USD | -3017.252% |
| Genscript Biotech Corporation | -95.47 Million USD | -245.951% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -1421051.364% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -7866.934% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -546393.492% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -453.038% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -10548.894% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -31177.1% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -16845.193% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -8548.966% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -16373.07% |
| BioStem Technologies, Inc. | -8.48 Million USD | -3793.724% |
| ONE Bio Corp. | 8.67 Million USD | 3906.832% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -74736.248% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -24633.887% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -18723.197% |
| Agentix Corp. | -1.37 Million USD | -23935.901% |
| LadRx Corporation | 400.44 Thousand USD | 82584.648% |
| Cell Source, Inc. | -5.32 Million USD | -6107.308% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -79399.566% |
| Regen BioPharma, Inc. | 1.02 Million USD | 32371.756% |
| Regen BioPharma, Inc. | 1.02 Million USD | 32371.756% |
| NovAccess Global Inc. | -4.76 Million USD | -6825.793% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 4870.013% |
| Itoco Inc. | -1.86 Million USD | -17572.813% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -7335.034% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -19690.533% |
| Kadimastem Ltd | -3.3 Million USD | -9886.823% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -120712.576% |
| CytoDyn Inc. | -49.84 Million USD | -562.715% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -417831.75% |
| Mobile Lads Corp. | -2.26 Million USD | -14493.963% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -144689.525% |
| Qrons Inc. | -789.34 Thousand USD | -41745.221% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -34981.66% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -15721.567% |
| Rebus Holdings, Inc. | -1.02 Million USD | -32282.745% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -20380.959% |
| International Stem Cell Corporation | -131 Thousand USD | -252040.458% |
| Bioxytran, Inc. | -4.28 Million USD | -7617.38% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -608508.491% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -12954.22% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -587.103% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -15524.598% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -42198.566% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -10326.263% |
| Neutra Corp. | -233.46 Thousand USD | -141379.023% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1527.835% |
| PureTech Health plc | -65.69 Million USD | -402.769% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -1453.163% |
| IXICO plc | -1.17 Million USD | -27939.389% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -3227.33% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -478.182% |
| CSL Limited | 2.64 Billion USD | 112.502% |
| Cellectis S.A. | -103.17 Million USD | -220.143% |